BiotechTube
Home/Vor Biopharma/Jean-Paul Kress, MD
JK

Jean-Paul Kress, MD

Chief Executive Officer and Chairman

Vor Biopharma

Therapeutic Areas

Autoimmune DiseasesRheumatologyNeurologyNephrology

Vor Biopharma Pipeline

DrugIndicationPhase
TelitaciceptGeneralized Myasthenia Gravis (MG)Phase 3

Leadership Team at Vor Biopharma

SM
Sandy Mahatme
Chief Financial Officer, Chief Business Officer
JS
Jeremy Sokolove, MD
Chief Medical Officer
DM
Dallan Murray
Chief Commercial Officer
AO
Adi Osovsky, SJD
General Counsel
NZ
Navid Z. Khan, PhD
Chief Medical Affairs Officer
CL
Carol Lincoln, CCP
Head of Human Resources
View full Vor Biopharma profile